AU2016215291B2 - Antibodies directed against Lymphocyte Activation Gene 3 (LAG-3) - Google Patents

Antibodies directed against Lymphocyte Activation Gene 3 (LAG-3) Download PDF

Info

Publication number
AU2016215291B2
AU2016215291B2 AU2016215291A AU2016215291A AU2016215291B2 AU 2016215291 B2 AU2016215291 B2 AU 2016215291B2 AU 2016215291 A AU2016215291 A AU 2016215291A AU 2016215291 A AU2016215291 A AU 2016215291A AU 2016215291 B2 AU2016215291 B2 AU 2016215291B2
Authority
AU
Australia
Prior art keywords
lag
directed against
antibodies directed
lymphocyte activation
activation gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016215291A
Other versions
AU2016215291A1 (en
Inventor
Peter Bowers
Helen Toni JUN
Marilyn Kehry
David J. King
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anaptysbio Inc
Original Assignee
Anaptysbio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anaptysbio Inc filed Critical Anaptysbio Inc
Publication of AU2016215291A1 publication Critical patent/AU2016215291A1/en
Application granted granted Critical
Publication of AU2016215291B2 publication Critical patent/AU2016215291B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2016215291A 2015-02-03 2016-02-03 Antibodies directed against Lymphocyte Activation Gene 3 (LAG-3) Active AU2016215291B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62/111,486 2015-02-03

Publications (2)

Publication Number Publication Date
AU2016215291A1 AU2016215291A1 (en) 2017-09-14
AU2016215291B2 true AU2016215291B2 (en) 2021-04-29

Family

ID=

Similar Documents

Publication Publication Date Title
HK1247618A1 (en) Antibodies directed against lymphocyte activation gene 3 (lag-3)
EP3635665A4 (en) Linked multiple blockchain system
EP3589313A4 (en) Anti-tigit antibodies
EP3481869A4 (en) Anti-cd73 antibodies
EP3503920A4 (en) Anti-ctla4 antibodies
EP3283110A4 (en) Antibodies directed against interleukin 36 receptor (il-36r)
EP3468327A4 (en) Component mounting system
EP3522922A4 (en) Novel anti-ctla4 antibodies
EP3661558A4 (en) Anti-il1rap antibodies
EP3606961B8 (en) Garp-tgf-beta antibodies
EP3468330A4 (en) Component supply system
EP3712287A4 (en) Nitration-treated component
EP3691447A4 (en) Anti-transthyretin antibodies
EP3528620A4 (en) Open-sea aquaculture system
EP3578694A4 (en) Electroplating device for small component
EP3526247A4 (en) Anti-il1-rap antibodies
EP3684156A4 (en) Component feeding system
EP3172324A4 (en) 5'-triphosphate oligoribonucleotides
EP3495004A4 (en) Biological component adhesion-suppressing material
EP3463414A4 (en) Protein interfaces
EP3518645A4 (en) Component supply system
EP3579879A4 (en) Anti-kir3dl1 antibodies
EP3468570A4 (en) Compositions for biological systems and methods for preparing and using the same
EP3851299A4 (en) Functional component
EP3383479A4 (en) Haemorrhage avoiding microelectrode